Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule that targets colony stimulating factor 1 receptor, KIT proto-oncogene receptor tyrosine kinase, and FMS-like tyrosine kinase 3 harboring an internal...
Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 81 3 6225 1111
Address:
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan
